RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that...

Today at the Association for Molecular Pathology's 2017 Annual Meeting (AMP), Edico Genome announced a new offering: the comprehensive DRAGEN Clinical Genomics Information System (CGIS). Designed...

The research firm announced executives from Itron and Meritage Homes will be keynote speakers at the ninth-annual Smart Energy Summit: Engaging the Consumer, February 19-21 at the Fairmont Hotel...

(Nasdaq: CELH) Celsius Holdings Inc., maker of the leading global fitness drink, CELSIUS®, today announced that John Fieldly, Interim President and Chief Executive Officer, will present at two...

Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, announced results from two retrospective, claims-based analyses providing health economic insights on the use of...